Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PTHS	PELTHOS THERAPEUTICS INC	$74.12M	-200.40%	-67.00%	-45.68%	-242.30%	2.35	2.06	76.30%	-257.90%	-283.98%
XTLB	XTL BIOPHARMACEUTICALS LTD	$7.17M	-26.80%	-18.70%	-18.24%	911.00%	0.57	0.61	0.70%	-227.70%	-256.54%
PRTC	PURETECH HEALTH PLC	$382.24M	14.70%	8.90%	10.48%	15.50%	0.49	8.49	100.00%	793.00%	840.87%
PSTV	PLUS THERAPEUTICS INC	$42.20M	N/A	-156.00%	-468.14%	331.30%	3.09	1.23	100.00%	-429.40%	-360.20%
PPCB	PROPANC BIOPHARMA INC	$1.78M	-471.70%	-356.20%	-568.83%	-426.90%	0.35	2.13	N/A	N/A	N/A
PPBT	PURPLE BIOTECH LTD	$7.70M	98.50%	83.40%	278.72%	-984.90%	0.82	1.27	N/A	N/A	N/A
INM	INMED PHARMACEUTICALS INC	$2.04M	-73.60%	-62.00%	-78.71%	-479.70%	0.17	5.94	29.70%	-170.10%	-169.63%
XRTX	XORTX THERAPEUTICS INC	$2.66M	-120.30%	-90.50%	-127.43%	-326.80%	0.29	2.11	N/A	N/A	N/A
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$22.47M	-70.60%	-55.50%	-75.50%	-361.90%	0.32	7.77	N/A	N/A	N/A
BCDA	BIOCARDIA INC	$13.13M	-28,372.40%	-238.20%	-838.74%	572.10%	2.81	1.12	N/A	N/A	N/A
PLUR	PLURI INC	$33.47M	N/A	-74.50%	1,431.31%	-77.20%	-2.26	0.43	40.60%	-1,952.10%	-1,870.65%
PBM	PSYENCE BIOMEDICAL LTD	$727.85k	N/A	N/A	N/A	N/A	0.08	8.09	N/A	N/A	N/A
PCSA	PROCESSA PHARMACEUTICALS INC	$6.12M	-257.80%	-191.10%	-243.20%	9,704.10%	0.40	2.54	N/A	N/A	N/A
LSTA	LISATA THERAPEUTICS INC	$45.25M	-84.40%	-70.80%	-119.59%	-1,297.70%	0.21	5.77	100.00%	-9,756.50%	-10,322.35%
ONCO	ONCONETIX INC	$2.17M	-213.90%	-75.30%	-84.11%	173.40%	0.58	0.66	77.60%	-1,904.80%	-1,628.81%
CMND	CLEARMIND MEDICINE INC	$1.08M	-207.50%	-100.70%	-80.17%	383.20%	0.35	3.79	N/A	N/A	N/A
OTLK	OUTLOOK THERAPEUTICS INC	$17.28M	N/A	-525.50%	337.73%	-1,435.90%	-1.47	0.35	-573.80%	-50,004.70%	-50,597.68%
ALLR	ALLARITY THERAPEUTICS INC	$17.71M	-112.00%	-64.90%	-125.80%	277.30%	0.73	2.33	N/A	N/A	N/A
ATON	ALPHATON CAPITAL CORP	$1.93M	-271.20%	-89.50%	-164.61%	-332.40%	2.26	0.88	N/A	N/A	N/A
LGVN	LONGEVERON INC	$22.64M	-199.80%	-143.20%	-367.74%	-1,872.50%	0.81	1.33	67.00%	-1,893.60%	-1,893.58%
ENVB	ENVERIC BIOSCIENCES INC	$1.18M	-403.40%	-279.50%	-281.40%	1,913.00%	0.26	4.60	N/A	N/A	N/A
NTRB	NUTRIBAND INC	$46.26M	-501.80%	-429.50%	-166.83%	-3,295.90%	0.12	7.53	33.50%	-1,518.30%	-559.93%
DWTX	DOGWOOD THERAPEUTICS INC	$77.16M	-147.80%	-37.80%	-38.96%	6,048.10%	0.20	2.76	N/A	N/A	N/A
NRSN	NEUROSENSE THERAPEUTICS LTD	$18.94M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
APM	APTORUM GROUP LTD	$8.00M	-9.00%	-11.50%	-11.35%	-10.60%	0.19	2.98	N/A	N/A	N/A
NCEL	NEWCELX LTD	$1.01M	N/A	-337.50%	N/A	363.90%	0.51	N/A	N/A	N/A	N/A
NEUP	NEUPHORIA THERAPEUTICS INC	$23.56M	-26.00%	-18.40%	-17.88%	227.90%	0.23	9.04	100.00%	-37.80%	-40.58%
NCNA	NUCANA PLC	$0.00	-190.00%	-130.50%	-71.37%	1,079.00%	0.23	5.60	N/A	N/A	N/A
RLYB	RALLYBIO CORP	$45.62M	-16.20%	-15.00%	-15.47%	-26.80%	0.07	14.51	100.00%	-1,046.40%	-1,046.39%
CLLS	CELLECTIS SA	$243.78M	-69.40%	-19.50%	-9.47%	-7.40%	3.28	1.62	100.00%	-84.90%	-21.30%
BGMS	BIO GREEN MED SOLUTION INC	$4.82M	-240.20%	-136.80%	-59.67%	375.20%	0.15	6.43	21.00%	-8,609.90%	-5,271.60%
ANTX	AN2 THERAPEUTICS INC	$131.54M	-55.00%	-49.10%	-66.08%	-78.30%	0.17	6.87	N/A	N/A	N/A
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$3.65M	-249.80%	-152.70%	-206.66%	-309.50%	0.50	3.78	N/A	N/A	N/A
AZTR	AZITRA INC	$4.10M	-344.60%	-228.40%	-276.43%	-648.90%	0.32	2.83	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$6.85M	-51.20%	-43.60%	-36.25%	1,048.00%	0.13	8.32	100.00%	-90.10%	-90.07%
MREO	MEREO BIOPHARMA GROUP PLC	$55.87M	-83.00%	-72.70%	-104.46%	5,063.80%	0.12	10.47	73.40%	-8,375.60%	-8,694.60%
CURX	CURANEX PHARMACEUTICALS INC	$14.68M	-33.30%	-31.10%	-8.96%	-48.10%	0.01	77.53	N/A	N/A	N/A
MOLN	MOLECULAR PARTNERS AG	$161.24M	-60.00%	-51.40%	-62.15%	-195.60%	0.27	8.79	N/A	N/A	N/A
MNOV	MEDICINOVA INC	$71.86M	-26.30%	-24.60%	-28.69%	-411.10%	0.10	8.16	7.60%	-2,928.80%	-2,927.32%
LTRN	LANTERN PHARMA INC	$24.83M	-126.00%	-97.40%	-197.36%	-232.80%	0.42	3.33	N/A	N/A	N/A
LNAI	LUNAI BIOWORKS INC	$9.72M	-1,241.30%	-359.70%	936.64%	728.20%	-1.49	0.03	N/A	N/A	N/A
LIMN	LIMINATUS PHARMA INC	$5.30M	N/A	N/A	N/A	N/A	-1.82	0.42	N/A	N/A	N/A
LEXX	LEXARIA BIOSCIENCE CORP	$19.29M	-209.60%	-168.30%	-234.89%	-4,098.00%	0.31	3.68	100.00%	-2,067.70%	-2,067.31%
TOVX	THERIVA BIOLOGICS INC	$10.23M	-209.40%	-73.70%	-84.11%	-149.10%	1.49	1.74	N/A	N/A	N/A
KZR	KEZAR LIFE SCIENCES INC	$47.45M	-62.50%	-51.80%	-71.92%	-77.80%	0.18	7.07	N/A	N/A	N/A
MBIO	MUSTANG BIO INC	$5.80M	-29.80%	-11.80%	-19.85%	20.90%	0.85	2.22	N/A	N/A	N/A
APRE	APREA THERAPEUTICS INC	$7.68M	-96.30%	-74.30%	-100.63%	625.40%	0.28	5.63	100.00%	-4,409.20%	-4,637.35%
ESLA	ESTRELLA IMMUNOPHARMA INC	$41.81M	N/A	-431.00%	126.01%	158.90%	-1.31	0.12	N/A	N/A	N/A
KAPA	KAIROS PHARMA LTD	$12.53M	-79.20%	-71.20%	-66.05%	-177.20%	0.05	16.56	N/A	N/A	N/A
ACLX	ARCELLX INC	$6.70B	-55.40%	-36.20%	-50.64%	-51.20%	0.50	4.44	100.00%	-1,027.30%	-1,135.61%
ARTL	ARTELO BIOSCIENCES INC	$3.44M	N/A	-344.80%	1,013.84%	383.00%	-3.20	0.17	N/A	N/A	N/A
ERNA	ERNEXA THERAPEUTICS INC	$6.15M	-1,263.20%	-228.80%	-518.27%	662.10%	1.43	1.01	N/A	N/A	N/A
ALZN	ALZAMEND NEURO INC	$7.34M	-192.40%	-152.20%	-322.04%	3,265.40%	0.85	1.99	N/A	N/A	N/A
EVGN	EVOGENE LTD	$7.39M	N/A	-29.70%	-39.71%	-43.90%	-98.43	4.54	-6.30%	-220.20%	-171.11%
JAGX	JAGUAR HEALTH INC	$1.55M	-710.60%	-79.50%	-303.13%	-119.10%	8.02	0.81	81.90%	-341.90%	-343.39%
AIM	AIM IMMUNOTECH INC	$2.43M	N/A	-257.40%	-1,047.35%	462.40%	-1.90	0.64	15.20%	-14,062.50%	-13,568.75%
ITRM	ITERUM THERAPEUTICS PLC	$9.08M	N/A	-74.80%	-94.04%	-83.90%	-5.40	2.14	-146.40%	-6,913.10%	-6,287.18%
EXOZ	EXOZYMES INC	$60.39M	-104.50%	-79.50%	-134.61%	-294.80%	0.44	4.53	N/A	N/A	N/A
BRTX	BIORESTORATIVE THERAPIES INC	$2.75M	-233.30%	-137.90%	-574.11%	-328.40%	1.56	1.37	93.30%	-3,304.80%	-3,304.77%
FBLG	FIBROBIOLOGICS INC	$17.85M	-785.80%	-170.70%	-234.63%	-455.90%	0.56	3.61	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$5.81M	-97.90%	-88.00%	-110.13%	5,105.70%	0.12	4.02	N/A	N/A	N/A
KPRX	KIORA PHARMACEUTICALS INC	$7.50M	-36.40%	-25.80%	-25.98%	-37.60%	0.33	8.80	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$14.36M	-60.10%	-42.90%	-43.58%	-52.50%	0.78	13.20	N/A	N/A	N/A
INDP	INDAPTUS THERAPEUTICS INC	$3.95M	-938.70%	-293.60%	-661.54%	937.70%	1.95	1.51	N/A	N/A	N/A
CNSP	CNS PHARMACEUTICALS INC	$1.69M	-130.10%	-107.10%	-131.74%	8,266.30%	0.20	5.82	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$1.05M	N/A	-80.10%	791.18%	-138.60%	-13.08	0.06	100.00%	-26,308.90%	-13,260.47%
ADTX	ADITXT INC	$63.64k	-757.20%	-156.60%	472.06%	-351.20%	-2.67	0.02	-1,111.20%	-710,498.70%	-703,444.47%
IOBT	IO BIOTECH INC	$13.89M	-465.40%	-180.60%	-407.32%	5,856.20%	42.86	2.01	N/A	N/A	N/A
ADIL	ADIAL PHARMACEUTICALS INC	$2.47M	-182.30%	-141.30%	-151.18%	2,490.20%	0.27	4.43	N/A	N/A	N/A
ICCC	IMMUCELL CORP	$58.26M	8.00%	5.10%	5.60%	4.60%	0.54	4.21	40.90%	8.40%	8.42%
INAB	IN8BIO INC	$15.85M	-111.30%	-88.10%	-66.76%	-270.50%	0.17	8.82	N/A	N/A	N/A
IMRN	IMMURON LTD	$6.29M	-39.70%	-34.00%	-34.91%	-154.80%	0.16	8.04	69.50%	-52.30%	-52.16%
INKT	MINK THERAPEUTICS INC	$42.83M	N/A	-180.10%	-807.47%	238.30%	-2.11	1.08	N/A	N/A	N/A
IGC	IGC PHARMA INC	$25.88M	-76.50%	-59.10%	-70.71%	-187.90%	0.31	0.83	37.60%	-445.60%	-445.62%
FOLD	AMICUS THERAPEUTICS INC	$4.53B	-12.00%	-3.20%	6.51%	6.50%	2.46	2.84	88.50%	-4.30%	7.31%
GDTC	CYTOMED THERAPEUTICS LTD	$12.23M	-42.40%	-38.10%	-47.70%	-75.20%	0.16	5.81	84.10%	-1,629.20%	-1,619.98%
GLMD	GALMED PHARMACEUTICALS LTD	$3.29M	-47.80%	-42.60%	-49.15%	-68.70%	0.13	7.98	N/A	N/A	N/A
IBO	IMPACT BIOMEDICAL INC	$62.86M	N/A	-63.40%	-83.88%	8,410.50%	0.15	0.35	-1,225.00%	-36,993.80%	-42,578.13%
IMMP	IMMUTEP LTD	$54.23M	-61.80%	-50.90%	-83.72%	-144.80%	0.49	2.97	100.00%	-777.70%	-777.30%
IMA	IMAGENEBIO INC	$62.19M	-41.30%	-36.70%	-32.24%	-70.80%	0.15	12.49	100.00%	-6,549.40%	-5,712.38%
GTBP	GT BIOPHARMA INC	$14.67M	-1,291.70%	-620.50%	-487.77%	2,412.00%	0.40	3.50	N/A	N/A	N/A
JUNS	JUPITER NEUROSCIENCES INC	$12.08M	-352.00%	-171.60%	-13,172.74%	-7,912.00%	43.87	0.65	N/A	N/A	N/A
ACXP	ACURX PHARMACEUTICALS INC	$12.19M	-215.60%	-128.70%	-151.21%	339.50%	0.46	3.18	N/A	N/A	N/A
CLDI	CALIDI BIOTHERAPEUTICS INC	$2.09M	-597.30%	-194.70%	-221.67%	-752.50%	0.99	2.12	N/A	N/A	N/A
GOSS	GOSSAMER BIO INC	$89.65M	N/A	-75.50%	-146.55%	-46.20%	-2.40	2.64	100.00%	-351.50%	-329.00%
OSRH	OSR HOLDINGS INC	$11.30M	N/A	N/A	N/A	N/A	0.53	0.21	N/A	N/A	N/A
SILO	SILO PHARMA INC	$5.06M	-107.00%	-77.10%	-89.35%	-366.70%	0.28	8.70	65.20%	-7,041.10%	-7,034.36%
ABVC	ABVC BIOPHARMA INC	$27.48M	-88.90%	-43.10%	-50.13%	-57.40%	0.70	0.41	N/A	N/A	N/A
IPHA	INNATE PHARMA SA	$111.28M	-271.40%	-37.70%	-65.09%	-71.60%	17.07	2.21	100.00%	-364.40%	-327.14%
TELO	TELOMIR PHARMACEUTICALS INC	$45.73M	-315.20%	-259.30%	-176.10%	1,626.80%	0.24	5.14	N/A	N/A	N/A
TPST	TEMPEST THERAPEUTICS INC	$7.73M	-310.90%	-125.10%	-261.69%	-289.60%	1.70	2.30	N/A	N/A	N/A
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$1.95B	-161.90%	-37.80%	-60.39%	-50.70%	3.56	1.54	90.90%	-296.80%	-277.82%
VIVS	VIVOSIM LABS INC	$4.43M	-15.60%	-11.30%	-27.02%	-112.10%	0.57	2.44	100.00%	-864.10%	-853.52%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$17.06M	-219.00%	-178.10%	-82.92%	-1,205.80%	0.11	10.42	N/A	N/A	N/A
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$6.91M	-85.60%	-82.40%	-79.67%	4,108.20%	0.04	25.97	63.40%	-99,916.80%	-99,916.80%
TTRX	TURN THERAPEUTICS INC	$100.41M	N/A	N/A	N/A	N/A	7.53	1.43	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$5.68M	-370.50%	-50.80%	-67.86%	-133.70%	102.78	1.12	N/A	N/A	N/A
TVGN	TEVOGEN BIO HOLDINGS INC	$20.58M	N/A	-771.10%	1,393.99%	-8,185.70%	-1.57	0.32	N/A	N/A	N/A
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$8.59M	-102.00%	-72.10%	-108.89%	-197.80%	0.51	3.66	63.00%	-491.30%	-504.08%
TRAW	TRAWS PHARMA INC	$15.98M	-2,912.00%	518.00%	2,048.95%	-1,528.40%	1.74	1.22	100.00%	3,280.00%	3,280.04%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Veracyte (NASDAQ:VCYT)

Veracyte (NASDAQ:VCYT) is the #1 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Veracyte (NASDAQ:VCYT) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Veracyte (NASDAQ:VCYT) has a Due Diligence Score of 59, which is 34 points higher than the biotech industry average of 25.

VCYT passed 19 out of 33 due diligence checks and has strong fundamentals. Veracyte has seen its stock lose -2.67% over the past year, overperforming other biotech stocks by 32 percentage points.

Veracyte has an average 1 year price target of $45.17, an upside of 37.75% from Veracyte's current stock price of $32.79.

Veracyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Veracyte, 50% have issued a Strong Buy rating, 16.67% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

2. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #2 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 30, which is 5 points higher than the biotech industry average of 25.

PHAR passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 86.1% over the past year, overperforming other biotech stocks by 121 percentage points.

Pharming Group Nv has an average 1 year price target of $39.00, an upside of 140.3% from Pharming Group Nv's current stock price of $16.23.

Pharming Group Nv stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Pharming Group Nv, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #3 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -9 points lower than the biotech industry average of 25. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 39.8% over the past year, overperforming other biotech stocks by 74 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $223.91, an upside of 18.42% from Jazz Pharmaceuticals's current stock price of $189.08.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 281.69%, which is 242 percentage points higher than the biotech industry average of 39.49%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 21.04%, which is -18 percentage points lower than the biotech industry average of 39.49%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.14%, which is -32 percentage points lower than the biotech industry average of 39.49%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.92% in the last day, and up 1.12% over the last week. Sarepta Therapeutics was the among the top gainers in the biotechnology industry, gaining 34.98% yesterday.

Sarepta Therapeutics shares are trading higher after the company announced that early results from Phase 1/2 studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 and SRP-1003 for myotonic dystrophy type 1. Also, the company generated proof-of-concept data for SRP-1001 and SRP-1003.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.37% in the past year. It has overperformed other stocks in the biotech industry by 18 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 48.57% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 13.46% in the past year. It has overperformed other stocks in the biotech industry by 48 percentage points.

Are biotech stocks a good buy now?

63.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.6% over the next year.

2.4% of biotech stocks have a Zen Rating of A (Strong Buy), 4.37% of biotech stocks are rated B (Buy), 47.38% are rated C (Hold), 34.28% are rated D (Sell), and 11.57% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 25.57x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.